The many complications and comorbidities faced by the aging population of HIV positive people in the United States constitute a rapidly growing medical crisis that has been woefully neglected by U.S. research efforts.
HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, Immune-based therapies, and Preventive Technologies in Development. By Polly Clayden, Lei Chou, Simon Collins, Mark Harrington, Richard Jefferys, Eleonora Jimenez, Scott Morgan, Tracy Swan, Javid Syed and Claire Wingfield.
Starting HAART: When to Take the First Step? 20 July, 2010 Click to view session Presenters included: Steven Deeks (United States) Professor of Medicine, University of California, San Francisco (UCSF) Peter Mugyenyi (Uganda) Director and Founder, Joint Clinical Research Center…
April 1, 2010 Mark Harrington, founding member and executive director of Treatment Action Group (TAG), a giant in the world of HIV/AIDS treatment and advocacy, can boast about many accomplishments: his paradigm-shifting work on the Treatment and Data committee of…
March 2010 Investments in health research at the National Institutes of Health (NIH) have paid enormous dividends in the health and well-being of people in the U.S. and around the world. HIV and AIDS research supported by NIH has saved…
Addressing Critical Challenges in TB/HIV Research & Program Implementation 1 December 2009, Cancun, Mexico Introduction About 70 activists, researchers, clinicians and public health experts participated in a TAG/Stop TB Partnership satellite meeting held prior to the 40th Union World Conference…
EMERGENCY COURSE CORRECTION REQUIRED Assessing President Obama’s Response to the Global AIDS Crisis December 1, 2009, marks President Obama’s first World AIDS Day in the White House and the first World AIDS Day for the newly elected Congress. The time…
7/10/2009 By Richard Jefferys On January 8, the Office of AIDS Research convened a two-day workshop to discuss genome-wide association scan (GWAS) studies in HIV infection. GWAS involve studying known variations in the human genetic code (called single nucleotide polymorphisms…
HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, and Microbicides in Development July 2009 By Lei Chou, Mark Harrington, Bob Huff, Richard Jefferys, Javid Syed, and Claire Wingfield TAG’s annual Pipeline Reportsurveys the developments in medicines and diagnostics most likely…